79.8
Artiva Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
189
FY25:
113
(positive)
Change from FY23 to FY25
millions USD
FY23:
25.3
FY24:
21.0
FY25:
18.3
Total assets
Change from FY23 to FY25
millions USD
FY23:
105
FY24:
210
FY25:
131
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
12.2
FY24:
12.3
FY25:
13.1
(negative)
Change from FY23 to FY25
millions USD
FY23:
38.5
FY24:
10.7
FY25:
7.88
(positive)
Change from FY23 to FY25
millions USD
FY23:
−162
FY24:
187
FY25:
110
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
210
FY25:
131
All amounts in millions USD